1. Home
  2. COHU vs NBTX Comparison

COHU vs NBTX Comparison

Compare COHU & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohu Inc.

COHU

Cohu Inc.

HOLD

Current Price

$58.35

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$37.81

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHU
NBTX
Founded
1947
2003
Country
United States
France
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
COHU
NBTX
Price
$58.35
$37.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$40.50
$36.00
AVG Volume (30 Days)
1.4M
69.3K
Earning Date
04-30-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$452,956,000.00
N/A
Revenue This Year
$14.38
$58.17
Revenue Next Year
$19.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.74
N/A
52 Week Low
$17.80
$4.79
52 Week High
$74.60
$57.14

Technical Indicators

Market Signals
Indicator
COHU
NBTX
Relative Strength Index (RSI) 48.42 53.57
Support Level $20.99 $30.15
Resistance Level $70.92 $41.89
Average True Range (ATR) 4.80 2.46
MACD -0.51 0.49
Stochastic Oscillator 10.99 77.87

Price Performance

Historical Comparison
COHU
NBTX

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads, and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection). Geographically, the company generates maximum revenue from the Philippines, followed by Taiwan, China, Malaysia, the United States, Singapore, and the Rest of the world.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: